Pharmaceuticals Companies
Explore Pharmaceutical companies developing, manufacturing, and marketing medicines, therapeutics, vaccines, and healthcare products.
Sorted by Revenue (Highest to Lowest). Click any column header to re-sort.
| S.No. | Company Profile | Revenue | Operating Profit | Operating Cash Flow | ROCE | Cash ROCE | Action | |
|---|---|---|---|---|---|---|---|---|
| 1. | Novo Nordisk A/S (NYSE: NVO) | $234.55 B | — | $4.20 B | — | — | Nov 14, 2026 | View Data |
| 2. | Johnson & Johnson (NYSE: JNJ) | $94.19 B | $32.58 B | $24.53 B | 32.87 % | 30.08 % | Nov 14, 2026 | View Data |
| 3. | Eli Lilly and Company (NYSE: LLY) | $65.18 B | $25.73 B | $16.81 B | 77.78 % | 63.36 % | Nov 14, 2026 | View Data |
| 4. | Pfizer Inc. (NYSE: PFE) | $62.58 B | $7.79 B | $11.70 B | 8.96 % | 13.53 % | Nov 14, 2026 | View Data |
| 5. | AbbVie Inc. (NYSE: ABBV) | $61.16 B | $15.08 B | $19.03 B | 0.46x | — | Nov 14, 2026 | View Data |
| 6. | Bristol-Myers Squibb Company (NYSE: BMY) | $48.19 B | $9.33 B | $14.16 B | 38.12 % | 76.63 % | Nov 14, 2026 | View Data |
| 7. | Abbott Laboratories (NYSE: ABT / NYSE Texas: ABT) | $44.33 B | $8.05 B | $9.57 B | 12.36 % | 18.13 % | Nov 14, 2026 | View Data |
| 8. | Gilead Sciences, Inc. (NASDAQ: GILD) | $28.80 B | — | — | — | — | Oct 20, 2026 | View Data |
| 9. | Clinuvel Pharmaceuticals Limited (NASDAQ: CUVL) | $64.32 M | $27.92 M | $12.91 M | 12.29 % | 6.84 % | Nov 14, 2026 | View Data |
| 10. | Merck & Co., Inc. (NYSE: MRK) | — | — | — | — | — | Nov 14, 2026 | View Data |
| 11. | Roche Holding AG (SWX: ROG) | — | — | — | — | — | Nov 13, 2026 | View Data |